While all studies discussed thus far highlight FTO’s oncogenic role in various cancers, FTO’s tumor suppressor function was recently uncovered by Zeng et al. They report reduced FTO expression in pancreatic cancers, which increased m6A levels on PJA2 promoting its decay via YTHDF2. The gene discussed is PJA2; the disease is pancreatic neoplasm.